We previously found that loss of Kmt2a led to downregulation of the aberrant “MN1-driven leukemic program”, suggesting that the aberrant expression of Hoxa9 and Meis1 in MN1-driven leukemia remained under the control of its physiologic regulator, Kmt2a [19]. Here, HOXA9 is linked to leukemia.